Clinical trial
Safety and Efficacy Study of Bugusan (BGS)to Treat Osteoporosis.
NCT00202956 · Taichung Veterans General Hospital, Other · Unknown status
Key facts
| NCT number | NCT00202956 |
|---|---|
| Title | Safety and Efficacy Study of Bugusan (BGS)to Treat Osteoporosis. |
| Official title | A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effects on Biomarkers and Safety of Bugusan (BGS) in Postmenopausal Patients With Osteoporosis. |
| Lead sponsor | Taichung Veterans General Hospital, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Bugusan |
| Start date | Jun 1, 2004 |
| Completion | May 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 20, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: